CLIN TRANSL MED 润色咨询

Clinical and Translational Medicine

出版年份：2012 年文章数：514 投稿命中率： 开通期刊会员，数据随心看

出版周期：季刊 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=896331, encodeId=c321896331ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Nov 02 17:10:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093801, encodeId=af342093801c6, content=偏重的研究方向：肿瘤<br>经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Fri Oct 14 17:25:04 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883496, encodeId=826b8834964a, content=一般under review多久？之后pending recommendation多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/d8edf3577aba4771b5e8f3bef3d1f970/cfffb88881a84895a5cdcd148fed4370.jpg, createdBy=43111650687, createdName=懒羊羊要当学霸, createdTime=Tue Sep 08 08:33:36 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916491, encodeId=b57391649102, content=pending recommendation已经快十天了，求问有经验的大佬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65613066784, createdName=毕业救命, createdTime=Thu Jan 14 12:33:18 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：生物医学;合成生物学;癌症治疗<br>经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；<br>第一投稿，格式审查一周；<br>第二，编辑部审查1周到两周；<br>第三，外审2到4周；<br>第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；<br>第五，小修，修会后先格式审查，再编辑部审查；<br>第六，接受，校稿，缴费<br>第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109664, encodeId=f255210966496, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Tue Jan 10 14:34:41 CST 2023, time=2023-01-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150951, encodeId=c6f32150951da, content=最近稿件处理这么慢，一周多了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Wed Aug 02 17:43:01 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=886530, encodeId=5de4886530d2, content=审稿速度:2.0<br>经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d491645792, createdName=goodhaha2, createdTime=Fri Sep 18 23:17:06 CST 2020, time=2020-09-18, status=1, ipAttribution=)]
    2020-11-02 Michael scofield123

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志

    26

    展开26条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=896331, encodeId=c321896331ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Nov 02 17:10:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093801, encodeId=af342093801c6, content=偏重的研究方向：肿瘤<br>经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Fri Oct 14 17:25:04 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883496, encodeId=826b8834964a, content=一般under review多久？之后pending recommendation多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/d8edf3577aba4771b5e8f3bef3d1f970/cfffb88881a84895a5cdcd148fed4370.jpg, createdBy=43111650687, createdName=懒羊羊要当学霸, createdTime=Tue Sep 08 08:33:36 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916491, encodeId=b57391649102, content=pending recommendation已经快十天了，求问有经验的大佬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65613066784, createdName=毕业救命, createdTime=Thu Jan 14 12:33:18 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：生物医学;合成生物学;癌症治疗<br>经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；<br>第一投稿，格式审查一周；<br>第二，编辑部审查1周到两周；<br>第三，外审2到4周；<br>第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；<br>第五，小修，修会后先格式审查，再编辑部审查；<br>第六，接受，校稿，缴费<br>第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109664, encodeId=f255210966496, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Tue Jan 10 14:34:41 CST 2023, time=2023-01-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150951, encodeId=c6f32150951da, content=最近稿件处理这么慢，一周多了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Wed Aug 02 17:43:01 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=886530, encodeId=5de4886530d2, content=审稿速度:2.0<br>经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d491645792, createdName=goodhaha2, createdTime=Fri Sep 18 23:17:06 CST 2020, time=2020-09-18, status=1, ipAttribution=)]
    2022-10-14 不忘初心方为始终

    偏重的研究方向：肿瘤
    经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！

    21

    展开21条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=896331, encodeId=c321896331ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Nov 02 17:10:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093801, encodeId=af342093801c6, content=偏重的研究方向：肿瘤<br>经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Fri Oct 14 17:25:04 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883496, encodeId=826b8834964a, content=一般under review多久？之后pending recommendation多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/d8edf3577aba4771b5e8f3bef3d1f970/cfffb88881a84895a5cdcd148fed4370.jpg, createdBy=43111650687, createdName=懒羊羊要当学霸, createdTime=Tue Sep 08 08:33:36 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916491, encodeId=b57391649102, content=pending recommendation已经快十天了，求问有经验的大佬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65613066784, createdName=毕业救命, createdTime=Thu Jan 14 12:33:18 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：生物医学;合成生物学;癌症治疗<br>经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；<br>第一投稿，格式审查一周；<br>第二，编辑部审查1周到两周；<br>第三，外审2到4周；<br>第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；<br>第五，小修，修会后先格式审查，再编辑部审查；<br>第六，接受，校稿，缴费<br>第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109664, encodeId=f255210966496, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Tue Jan 10 14:34:41 CST 2023, time=2023-01-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150951, encodeId=c6f32150951da, content=最近稿件处理这么慢，一周多了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Wed Aug 02 17:43:01 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=886530, encodeId=5de4886530d2, content=审稿速度:2.0<br>经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d491645792, createdName=goodhaha2, createdTime=Fri Sep 18 23:17:06 CST 2020, time=2020-09-18, status=1, ipAttribution=)]
    2020-09-08 懒羊羊要当学霸

    一般under review多久？之后pending recommendation多久

    19

    展开19条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=896331, encodeId=c321896331ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Nov 02 17:10:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093801, encodeId=af342093801c6, content=偏重的研究方向：肿瘤<br>经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Fri Oct 14 17:25:04 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883496, encodeId=826b8834964a, content=一般under review多久？之后pending recommendation多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/d8edf3577aba4771b5e8f3bef3d1f970/cfffb88881a84895a5cdcd148fed4370.jpg, createdBy=43111650687, createdName=懒羊羊要当学霸, createdTime=Tue Sep 08 08:33:36 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916491, encodeId=b57391649102, content=pending recommendation已经快十天了，求问有经验的大佬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65613066784, createdName=毕业救命, createdTime=Thu Jan 14 12:33:18 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：生物医学;合成生物学;癌症治疗<br>经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；<br>第一投稿，格式审查一周；<br>第二，编辑部审查1周到两周；<br>第三，外审2到4周；<br>第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；<br>第五，小修，修会后先格式审查，再编辑部审查；<br>第六，接受，校稿，缴费<br>第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109664, encodeId=f255210966496, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Tue Jan 10 14:34:41 CST 2023, time=2023-01-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150951, encodeId=c6f32150951da, content=最近稿件处理这么慢，一周多了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Wed Aug 02 17:43:01 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=886530, encodeId=5de4886530d2, content=审稿速度:2.0<br>经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d491645792, createdName=goodhaha2, createdTime=Fri Sep 18 23:17:06 CST 2020, time=2020-09-18, status=1, ipAttribution=)]
    2021-01-14 毕业救命

    pending recommendation已经快十天了，求问有经验的大佬

    17

    展开17条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=896331, encodeId=c321896331ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Nov 02 17:10:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093801, encodeId=af342093801c6, content=偏重的研究方向：肿瘤<br>经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Fri Oct 14 17:25:04 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883496, encodeId=826b8834964a, content=一般under review多久？之后pending recommendation多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/d8edf3577aba4771b5e8f3bef3d1f970/cfffb88881a84895a5cdcd148fed4370.jpg, createdBy=43111650687, createdName=懒羊羊要当学霸, createdTime=Tue Sep 08 08:33:36 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916491, encodeId=b57391649102, content=pending recommendation已经快十天了，求问有经验的大佬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65613066784, createdName=毕业救命, createdTime=Thu Jan 14 12:33:18 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：生物医学;合成生物学;癌症治疗<br>经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；<br>第一投稿，格式审查一周；<br>第二，编辑部审查1周到两周；<br>第三，外审2到4周；<br>第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；<br>第五，小修，修会后先格式审查，再编辑部审查；<br>第六，接受，校稿，缴费<br>第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109664, encodeId=f255210966496, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Tue Jan 10 14:34:41 CST 2023, time=2023-01-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150951, encodeId=c6f32150951da, content=最近稿件处理这么慢，一周多了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Wed Aug 02 17:43:01 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=886530, encodeId=5de4886530d2, content=审稿速度:2.0<br>经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d491645792, createdName=goodhaha2, createdTime=Fri Sep 18 23:17:06 CST 2020, time=2020-09-18, status=1, ipAttribution=)]
    2023-08-21 1481ab03m35(暂无昵称) 来自上海

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向：生物医学;合成生物学;癌症治疗
    经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；
    第一投稿，格式审查一周；
    第二，编辑部审查1周到两周；
    第三，外审2到4周；
    第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；
    第五，小修，修会后先格式审查，再编辑部审查；
    第六，接受，校稿，缴费
    第七，In production 等出版

    16

    展开16条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=896331, encodeId=c321896331ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Nov 02 17:10:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093801, encodeId=af342093801c6, content=偏重的研究方向：肿瘤<br>经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Fri Oct 14 17:25:04 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883496, encodeId=826b8834964a, content=一般under review多久？之后pending recommendation多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/d8edf3577aba4771b5e8f3bef3d1f970/cfffb88881a84895a5cdcd148fed4370.jpg, createdBy=43111650687, createdName=懒羊羊要当学霸, createdTime=Tue Sep 08 08:33:36 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916491, encodeId=b57391649102, content=pending recommendation已经快十天了，求问有经验的大佬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65613066784, createdName=毕业救命, createdTime=Thu Jan 14 12:33:18 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：生物医学;合成生物学;癌症治疗<br>经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；<br>第一投稿，格式审查一周；<br>第二，编辑部审查1周到两周；<br>第三，外审2到4周；<br>第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；<br>第五，小修，修会后先格式审查，再编辑部审查；<br>第六，接受，校稿，缴费<br>第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109664, encodeId=f255210966496, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Tue Jan 10 14:34:41 CST 2023, time=2023-01-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150951, encodeId=c6f32150951da, content=最近稿件处理这么慢，一周多了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Wed Aug 02 17:43:01 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=886530, encodeId=5de4886530d2, content=审稿速度:2.0<br>经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d491645792, createdName=goodhaha2, createdTime=Fri Sep 18 23:17:06 CST 2020, time=2020-09-18, status=1, ipAttribution=)]
    2021-04-03 148c69cbm40暂无昵称

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online

    12

    展开12条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=896331, encodeId=c321896331ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Nov 02 17:10:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093801, encodeId=af342093801c6, content=偏重的研究方向：肿瘤<br>经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Fri Oct 14 17:25:04 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883496, encodeId=826b8834964a, content=一般under review多久？之后pending recommendation多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/d8edf3577aba4771b5e8f3bef3d1f970/cfffb88881a84895a5cdcd148fed4370.jpg, createdBy=43111650687, createdName=懒羊羊要当学霸, createdTime=Tue Sep 08 08:33:36 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916491, encodeId=b57391649102, content=pending recommendation已经快十天了，求问有经验的大佬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65613066784, createdName=毕业救命, createdTime=Thu Jan 14 12:33:18 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：生物医学;合成生物学;癌症治疗<br>经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；<br>第一投稿，格式审查一周；<br>第二，编辑部审查1周到两周；<br>第三，外审2到4周；<br>第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；<br>第五，小修，修会后先格式审查，再编辑部审查；<br>第六，接受，校稿，缴费<br>第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109664, encodeId=f255210966496, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Tue Jan 10 14:34:41 CST 2023, time=2023-01-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150951, encodeId=c6f32150951da, content=最近稿件处理这么慢，一周多了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Wed Aug 02 17:43:01 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=886530, encodeId=5de4886530d2, content=审稿速度:2.0<br>经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d491645792, createdName=goodhaha2, createdTime=Fri Sep 18 23:17:06 CST 2020, time=2020-09-18, status=1, ipAttribution=)]
    2021-12-07 ms5000002112552282

    求问under initial checking6天，直接pending decision是要凉了吗

    11

    展开11条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=896331, encodeId=c321896331ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Nov 02 17:10:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093801, encodeId=af342093801c6, content=偏重的研究方向：肿瘤<br>经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Fri Oct 14 17:25:04 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883496, encodeId=826b8834964a, content=一般under review多久？之后pending recommendation多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/d8edf3577aba4771b5e8f3bef3d1f970/cfffb88881a84895a5cdcd148fed4370.jpg, createdBy=43111650687, createdName=懒羊羊要当学霸, createdTime=Tue Sep 08 08:33:36 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916491, encodeId=b57391649102, content=pending recommendation已经快十天了，求问有经验的大佬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65613066784, createdName=毕业救命, createdTime=Thu Jan 14 12:33:18 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：生物医学;合成生物学;癌症治疗<br>经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；<br>第一投稿，格式审查一周；<br>第二，编辑部审查1周到两周；<br>第三，外审2到4周；<br>第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；<br>第五，小修，修会后先格式审查，再编辑部审查；<br>第六，接受，校稿，缴费<br>第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109664, encodeId=f255210966496, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Tue Jan 10 14:34:41 CST 2023, time=2023-01-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150951, encodeId=c6f32150951da, content=最近稿件处理这么慢，一周多了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Wed Aug 02 17:43:01 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=886530, encodeId=5de4886530d2, content=审稿速度:2.0<br>经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d491645792, createdName=goodhaha2, createdTime=Fri Sep 18 23:17:06 CST 2020, time=2020-09-18, status=1, ipAttribution=)]
    2023-01-10 小闪电 来自浙江省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：免疫;肿瘤
    经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！

    11

    展开11条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=896331, encodeId=c321896331ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Nov 02 17:10:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093801, encodeId=af342093801c6, content=偏重的研究方向：肿瘤<br>经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Fri Oct 14 17:25:04 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883496, encodeId=826b8834964a, content=一般under review多久？之后pending recommendation多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/d8edf3577aba4771b5e8f3bef3d1f970/cfffb88881a84895a5cdcd148fed4370.jpg, createdBy=43111650687, createdName=懒羊羊要当学霸, createdTime=Tue Sep 08 08:33:36 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916491, encodeId=b57391649102, content=pending recommendation已经快十天了，求问有经验的大佬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65613066784, createdName=毕业救命, createdTime=Thu Jan 14 12:33:18 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：生物医学;合成生物学;癌症治疗<br>经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；<br>第一投稿，格式审查一周；<br>第二，编辑部审查1周到两周；<br>第三，外审2到4周；<br>第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；<br>第五，小修，修会后先格式审查，再编辑部审查；<br>第六，接受，校稿，缴费<br>第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109664, encodeId=f255210966496, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Tue Jan 10 14:34:41 CST 2023, time=2023-01-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150951, encodeId=c6f32150951da, content=最近稿件处理这么慢，一周多了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Wed Aug 02 17:43:01 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=886530, encodeId=5de4886530d2, content=审稿速度:2.0<br>经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d491645792, createdName=goodhaha2, createdTime=Fri Sep 18 23:17:06 CST 2020, time=2020-09-18, status=1, ipAttribution=)]
    2023-08-02 ms3000001344629820 来自陕西省

    最近稿件处理这么慢，一周多了还没分配编辑

    11

    展开11条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=896331, encodeId=c321896331ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：挺有潜力的一个杂志，一审18天，二审17天，三审一周！一审6个审稿人，将近八十个问题，非常仔细，对文章构架以及创新性都有所要求！估计明年9-10，强推此杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Mon Nov 02 17:10:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093801, encodeId=af342093801c6, content=偏重的研究方向：肿瘤<br>经验分享：兄弟姐妹们，骂归骂，但是明年CTM的影响因子能到多少啊？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Fri Oct 14 17:25:04 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883496, encodeId=826b8834964a, content=一般under review多久？之后pending recommendation多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/d8edf3577aba4771b5e8f3bef3d1f970/cfffb88881a84895a5cdcd148fed4370.jpg, createdBy=43111650687, createdName=懒羊羊要当学霸, createdTime=Tue Sep 08 08:33:36 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916491, encodeId=b57391649102, content=pending recommendation已经快十天了，求问有经验的大佬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65613066784, createdName=毕业救命, createdTime=Thu Jan 14 12:33:18 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：生物医学;合成生物学;癌症治疗<br>经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；<br>第一投稿，格式审查一周；<br>第二，编辑部审查1周到两周；<br>第三，外审2到4周；<br>第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；<br>第五，小修，修会后先格式审查，再编辑部审查；<br>第六，接受，校稿，缴费<br>第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109664, encodeId=f255210966496, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审一个月回来，4个审稿人，两个大修两个小修，编辑给了大修，并且提了很多额外的要求。二审重新送审，5天变成pending recommendation，一周状态未变。老天保佑，希望能中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Tue Jan 10 14:34:41 CST 2023, time=2023-01-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2150951, encodeId=c6f32150951da, content=最近稿件处理这么慢，一周多了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Wed Aug 02 17:43:01 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=886530, encodeId=5de4886530d2, content=审稿速度:2.0<br>经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d491645792, createdName=goodhaha2, createdTime=Fri Sep 18 23:17:06 CST 2020, time=2020-09-18, status=1, ipAttribution=)]
    2020-09-18 goodhaha2

    审稿速度:2.0
    经验分享：非常反感杂志的毫无信用。让我把文章改为letter，我辛辛苦苦的改了之后，1个多月就被拒了，连专家评审意见都没有，发邮件也不回。我怀疑没有评审。我从小道消息获知，这个杂志有关系是非常重要的

    11

    展开11条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分